Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Cell2016Vol. 166(3), pp. 755–765
Citations Over TimeTop 1% of 2016 papers
Hui Zhang, Tao Liu, Zhen Zhang, Samuel Payne, Bai Zhang, Jason McDermott, Jianying Zhou, Vladislav Petyuk, Li Chen, Debjit Ray, Shisheng Sun, Feng Yang, Lijun Chen, Jing Wang, Punit Shah, Seong Won, Paul Aiyetan, Sunghee Woo, Yuan Tian, Marina Gritsenko, Therese RW Clauss, Caitlin H. Choi, Matthew Monroe, Stefani N. Thomas, Song Nie, Chaochao Wu, Ronald Moore, Kun‐Hsing Yu, David L. Tabb, David Fenyö, Vineet Bafna, Yue Wang, Henry Rodriguez, Emily S. Boja, Tara Hiltke, Robert Rivers, Lori J. Sokoll, Heng Zhu, Ie−Ming Shih, Leslie Cope, Akhilesh Pandey, Bing Zhang, M Snyder, Douglas A. Levine, Richard Smith, Daniel W. Chan, Karin Rodland, Steven A. Carr, Michael A. Gillette, Karl R. Klauser, Eric Kuhn, D.R. Mani, Philipp Mertins, Karen A. Ketchum, Ratna R. Thangudu, Shuang Cai, Mauricio Oberti, Amanda G. Paulovich, Jeffrey R. Whiteaker, Nathan Edwards, Peter B. McGarvey, Subha Madhavan, Pei Wang, Daniel W. Chan, Akhilesh Pandey, Ie−Ming Shih, Hui Zhang, Zhen Zhang, Heng Zhu, Leslie Cope, Gordon A. Whiteley, Steven J. Skates, Forest M. White, Douglas A. Levine, Emily S. Boja, Christopher R. Kinsinger, Tara Hiltke, Mehdi Mesri, Robert Rivers, Henry Rodriguez, Kenna M. Shaw, Stephen E. Stein, David Fenyö, Tao Liu, Jason McDermott, Samuel Payne, Karin Rodland, Richard Smith, Paul A. Rudnick, M Snyder, Yingming Zhao, Xian Chen, David F. Ransohoff, Andrew N. Hoofnagle, D.C. Liebler, Melinda E. Sanders, Zhiao Shi, Robbert J.C. Slebos, David L. Tabb, Bing Zhang, Lisa J. Zimmerman, Yue Wang, Sherri R. Davies, Li Ding, Matthew J. Ellis, R. Reid Townsend
Related Papers
- → Proteogenomics meets cancer immunology: mass spectrometric discovery and analysis of neoantigens(2015)36 cited
- → Proteogenomics for understanding oncology: recent advances and future prospects(2015)20 cited
- → Diagnosis shift between low-grade serous ovarian cancer and serous borderline ovarian tumor: A population-based study(2020)1 cited
- → Selective activation of Notch3 in high-grade serous ovarian cancer(2014)
- Expression and diagnostic value of HE4 level in early serous ovarian(2013)